In-depth, public interest health journalism.

Shorter, simpler DR-TB regimen expected later this year

Posted in: Edition 10: Drug-resistant TB, Latest, NSP and SANAC, TB, TB

A new six-month treatment regimen for drug-resistant forms of tuberculosis is expected to be rolled out in the public sector later this year – current regimens take anything from nine to 18 months. Catherine Tomlinson unpacks why the switch is important and outlines what still needs to happen to make it a reality.

Shorter, simpler DR-TB regimen expected later this year

TB treatment time cut by a third

Posted in: Edition 10: Drug-resistant TB, Edition 7: TB, HIV/AIDS, Latest, TB

A new four-month treatment course for drug-sensitive tuberculosis (the most common form of TB by far) is as safe and effective as the current six-month treatment course that has been in use since the 1980s, according to findings from a large new study. Amy Green reports.